| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.70B | $1.57B | $1.53B |
| YoY Revenue Growth % | +8.3% | +2.4% | — |
| Gross Profit | $764.8M | $707.0M | — |
| Gross Margin % | 45.1% | 45.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $278.9M | $244.6M | $191.4M |
| Operating Margin % | 16.4% | 15.6% | 12.5% |
| Net Income (GAAP) | $198.0M | $160.2M | $112.7M |
| EBITDA (Normalized) | $340.0M | $301.0M | $246.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $346.5M | $293.5M | $253.9M |
| Capital Expenditures (CapEx) | $76.3M | $70.5M | $68.9M |
| Free Cash Flow (FCF) | $270.2M | $223.0M | $185.0M |
| FCF Margin % | 15.9% | 14.2% | 12.1% |
| Return on Invested Capital (ROIC %) | 12.3% | 10.3% | 6.2% |
| Cash & Short-Term Equivalents | $300.5M | $198.0M | — |
| Total Debt (Short + Long Term) | $495.6M | $494.8M | $950.4M |
| Total Stockholders' Equity | $1.60B | $1.59B | $1.95B |